HopeStage
Back to all studies
TerminatedNCT01913327

Antipsychotic Effects on Brain Function in Schizophrenia

Medication studyAges 18–40United States
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 40 years. Other eligibility criteria apply.

Listed locations
San FranciscoSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateApril 2013
Recruitment status
Terminated
Enrollment listed in the registry
4
Sponsor
University of California, San Francisco
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 40 Years
Official registry ID
NCT01913327
Official title
Show the full official title

Locus Coeruleus Neuroimaging of Antipsychotic/Modafinil Interactions on Cognition in Schizophrenia

Recruitment & locations

Terminated

San Francisco

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, San Francisco, a university.

Does this study involve medication?

Yes. The study involves medication, including Aripiprazole, Risperidone and Modafinil.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 40 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies